Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape (Q73181590)
Jump to navigation
Jump to search
scientific article published on 01 July 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape |
scientific article published on 01 July 1999 |
Statements
Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape (English)
B Escudier
C Chevreau
C Lasset
J Y Douillard
M Fabbro
A Caty
J F Rossi
P Viens
J P Bergerat
J Savary